Karin J. Stebbins

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

Feng Mei, Klaus Lehmann‐Horn, Yun‐An Shen et al. · eLife · 2016 · 308 citations · Full text

Inflammatory Demyelination, Immunology, Peripheral Nerves +17

Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

William C. Shakespeare, Michael G. Yang, Regine S. Bohacek et al. · Proceedings of the National Academy of Sciences · 2000 · 133 citations · Full text

Medicinal Chemistry, Sclerostin, Biochemistry +15

Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease

John Doukas, Lisa Eide, Karin J. Stebbins et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 102 citations

Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy

Christian Cordano, Jung Hyung Sin, Garrett Timmons et al. · Brain · 2022 · 64 citations · Full text

Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation

Karin J. Stebbins, Alex Broadhead, Lucia Correa et al. · European Journal of Pharmacology · 2010 · 49 citations

Inflammation, Allergy, Lung Inflammation +10